ClinicalTrials.gov
ClinicalTrials.gov Menu

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00135941
Recruitment Status : Completed
First Posted : August 26, 2005
Last Update Posted : June 4, 2009
Sponsor:
Information provided by:
Sanofi